MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$15.09 USD
-0.26 (-1.69%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $15.08 -0.01 (-0.07%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, MiNK Therapeutics, Inc. has a market cap of $69.43M, which represents its share price of $15.35 multiplied by its outstanding shares number of 4.52M. As a small-cap company, INKT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
INKT 15.09 -0.26(-1.69%)
Will INKT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INKT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INKT
New Strong Sell Stocks for August 22nd
INKT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INKT
Is INKT poised for gains? 20 Day Moving Average Support shows up after sliding 1.69%
Crossed Above 20 Day Moving Average appears for INKT after 7.79% move
Is INKT showing downside potential? 20 Day Moving Average Resistance shows up after sliding 2.4%
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases